Results 241 to 250 of about 39,064 (303)

Biosimilars versus biological therapy in inflammatory bowel disease: challenges and targeting strategies using drug delivery systems. [PDF]

Clin Exp Med
Aljabri A, Soliman GM, Ramadan YN, Medhat MA, Hetta HF.   +4 more
europepmc   +1 more source

Assessing biosimilarity using the method of generalized pivotal quantities [PDF]

, 2013
Shih‐Ting Chiu
openalex   +1 more source

Safety, efficacy and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis

British Journal of Dermatology, 2018
A. Egeberg, M. Ottosen, R. Gniadecki, S. Broesby‐Olsen, T. N. Dam, L. E. Bryld, M. Rasmussen, L. Skov   +7 more
semanticscholar   +1 more source

Ensuring Sustainability in Pharmaceutical Care: A Retrospective Analysis of Administrative Databases on the Utilization, Costs, and Switching Patterns of Biological Therapies in the Agency for Health Protection of the Metropolitan Area of Milan. [PDF]

Pharmaceuticals (Basel)
Langfelder RMB, Langella R, D'Angelo C, Panico C, Cattaneo S.   +4 more
europepmc   +1 more source

Facilitators and barriers to generic and biosimilar medications in the Middle East and North Africa: insights from physicians and pharmacists-a systematic review. [PDF]

Eur J Clin Pharmacol
Alqawasmeh KA, Mason T, Morris A, Hafez W, Hasan T, Taher S, Al Dweik R.   +6 more
europepmc   +1 more source

Nomenclature and Traceability Debate for Biosimilars: Small-Molecule Surrogates Lend Support for Distinguishable Nonproprietary Names [PDF]

, 2015

core   +1 more source

Dose Tapering of Advanced Therapies in Psoriatic Arthritis: Clinical Predictors and Outcomes in a Biosimilar-Dominant Real-Life Cohort. [PDF]

J Clin Med
Loredo M, Pardo E, Braña I, Burger S, Chiminazzo V, Queiro R.   +5 more
europepmc   +1 more source

A Look Beyond the Biosimilarity of the Molecules. [PDF]

, 2015
Michetti, P.
core   +1 more source

Comparative Safety Profiles of Biosimilars vs. Originators Used in Rheumatology: A Pharmacovigilance Analysis of the EudraVigilance Database. [PDF]

J Clin Med
Nikitina V, Laurini GS, Montanaro N, Motola D.   +3 more
europepmc   +1 more source

Generics, Biosimilars and Follow-On Non-Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European Neurologists. [PDF]

Eur J Neurol
Berger T, Zeitlinger M, Popescu V, Magyari M, Airas L, Alkhawajah M, Pugliatti M, Zakaria M, Pozzilli C, Drulovic J, Van Wijmeersch B, Vermersch P, Oreja-Guevara C.   +12 more
europepmc   +1 more source